Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (26)

« Back to Publications

Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study.

Kasbergen LMR. et al, (2025), Lancet Infect Dis, 25, 678 - 689

Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study.

Sigfrid L. et al, (2025), Lancet Infect Dis, 25, 690 - 700

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.

Citarella BW. et al, (2024), Heliyon, 10

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.

Reyes LF. et al, (2023), J Crit Care, 77

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.

Roper KJ. et al, (2023), Sci Rep, 13

Standardized data collection can lead to more insightful outcomes

LEE J., (2023), British Journal of Sports Medicine

Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study

Vink E. et al, (2022), Open Forum Infectious Diseases, 9

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.

ISARIC Clinical Characterization Group . et al, (2022), Sci Data, 9

Perpetual Observational Studies: New strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

HORBY P., (2022), Clinical Microbiology and Infection

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.

Wainstein M. et al, (2022), PLoS Med, 19

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study of the ISARIC cohort

Wainstein M. et al, (2022)

The value of open-source clinical science in pandemic response: lessons from ISARIC

HORBY P. et al, (2021), The Lancet Infectious Diseases

A prenylated dsRNA sensor protects against severe COVID-19.

Wickenhagen A. et al, (2021), Science (New York, N.Y.), 374, eabj3624 - eabj3624

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Drake TM. et al, (2021), The Lancet, 398, 223 - 237

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Leclerc QJ. et al, (2021), BMC Health Services Research

Load More